Skip to main content

Table 1 Baseline characteristics of pregnant women by treatment arm

From: Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial

Characteristics

Intervention arm SPAZ (n = 496)

Control arm SP (n = 496)

Age (years (mean, sd))

26 ± 6

25 ± 6

Body mass index (kg/m2 (mean, sd))

23.3 ± 3.5

23.3 ± 3.6

Height (cm, (mean, sd))

163 ± 6

162 ± 6

Fundal height (cm, (mean, sd))

20.5 ± 2.2

20.4 ± 2.4

Gestational age (weeks (mean, sd))

22.4 ± 2.0

22.4 ± 2.0

Hemoglobin at inclusion (g/dL (mean, sd))

10.5 ± 1.3

10.5 ± 1.4

Anemia (Hb < 11 g/dL) (n, %)

219 (60.2)

215 (59.4)

Pregnancy number (n, %)

       Primigravidae (1)

143 (28.8)

149 (30.0)

      Secundigravidae (2)

103 (20.8)

121 (24.4)

      Multigravida (≥ 3)

250 (50.4)

226 (45.6)

 Bed net use the night prior enrolment (n, %)

383 (77.2)

406 (81.9)

 Detected parasitemia at inclusion (n, %)

70 (14.6)

84 (17.4)

 Literate woman (n, %)

287 (57.9)

288 (58.1)

 Having income-generating activities (n, %)

82 (16.6)

98 (19.8)

 Maternal history of miscarriage /stillbirth (n, %)

77 (15.5)

80 (16.1)

 IPTp-SP uptake before enrolment (n, %)

28 (5.6)

40 (8.1)

  1. SP Sulfadoxine-pyrimethamine, SPAZ sulfadoxine-pyrimethamine plus azithromycin, g/dL gram per deciliter, cm centimeter, kg kilogram, m2 square meter, n total number per category